Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
It is projected that in the absence of effective therapy, most individuals infected with human
immunodeficiency
virus (HIV) will develop acquired immune deficiency syndrome (AIDS) and ultimately succumb to a combination of opportunistic microbial infections, malignancies and direct pathogenic effects of the virus. Anti-viral agents, immunomodulators, and inhibitors of specific HIV functions are being tested as potential treatments to alleviate the high morbidity and mortality. An alternative therapeutic concept involves the development of cytotoxic agents that are targeted to kill HIV-infected cells. Here we describe the purification and characterization of a recombinant protein produced in Escherichia coli that contains the HIV-binding portion of the human CD4 molecule linked to active regions of
Pseudomonas
exotoxin A. This hybrid protein displays selective toxicity toward cells expressing the HIV envelope glycoprotein and thus represents a promising novel therapeutic agent for the treatment of AIDS.
...
PMID:Selective killing of HIV-infected cells by recombinant human CD4-Pseudomonas exotoxin hybrid protein. 284 74
During the year 1985, 462 cases of septicemia were collected by SES group; 417 observations could be exploited. 73 patients died (17.3%). The statistical analysis of epidemiological and clinical data argued to factors correlated with high mortality rate: a shock, an acute respiratory distress syndrome, a pulmonary portal of entry lead to a high mortality rate. The fatal outcome increased with the age of the patients. A documented
immunodeficiency
(granulopenia, cytotoxic chemotherapy...), a previous broncho-pulmonary, neurologic or cardiovascular disease were factors of risk. The pulmonary or cutaneous localisations occurring within a septicemic phase were significantly related to death. Among fatal cases of bacteremia, 25% were Staphylococci, 25% Enterobacteria, 20% Pneumococci, 7%
Pseudomonas
.
Pseudomonas
, then Pneumococcus, then Staphylococcus bacteremias looks to have a worse prognosis. The more serious cases were prescribed several antibiotics, significantly much more than the mild cases. These results are compared with the results of former series; the main prognosis factors of actual septicemia are elicited in here.
...
PMID:[Fatal septicemias: factors of mortality. Analysis of 72 fatal cases in the series of 462 case reports collected by the Septicemia Expert System group in 1985]. 330 21
Forty-nine episodes of bacteremia and fungemia occurred in 38 of 336 patients with the acquired immunodeficiency syndrome seen at our institution since 1980. There were five types of infections. Infections commonly associated with a T-cell
immunodeficiency
disorder comprised 16 episodes and included those with Salmonella species, Listeria monocytogenes, Cryptococcus neoformans, and Histoplasma capsulatum. Infections commonly associated with a B-cell
immunodeficiency
disorder included those with Streptococcus pneumoniae and Haemophilus influenzae. Infections occurring with neutropenia were caused by
Pseudomonas
aeruginosa, Staphylococcus epidermidis, and Streptococcus faecalis. Other infections occurring in the hospital were caused by Candida albicans, Staphylococcus epidermidis, enteric gram-negative rods, Staphylococcus aureus, and mixed S. aureus and group G streptococcus. Other infections occurring out of the hospital included those with S. aureus, Clostridium perfringens, Shigella sonnei,
Pseudomonas
aeruginosa, and group B streptococcus. Because two thirds of the septicemias were caused by organisms other than T-cell opportunists, these pathogens should be anticipated during diagnostic evaluation and when formulating empiric therapy.
...
PMID:Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome. 348 96
Otitis externa are of usual observation in inter-tropical regions.
Pseudomonas
aeruginosa is responsible generally. But, when
immunodeficiency
is associated or on diabetic diathesis, such an otitis externa can be extremely dangerous: extensive osteitis of the base of the skull, paralysis of the last pairs of cervical nerves rapidly creeping, built a clinical identity called malignant external otitis, leading to death in 50% of the cases.
...
PMID:[A severe form of external otitis: necrosing diabetic otitis]. 358 74
Sinusitis tends to occur in immunodeficient and immunosuppressed patients during periods of severe leukopenia. This group of patients includes those with primary
immunodeficiency
diseases, patients with leukemia receiving chemotherapy, and those undergoing bone marrow transplantation or kidney transplantation. The clinical and radiographic signs may be minimal or initially unimpressive. Sinusitis due to Aspergillus, Phycomycetes, or
Pseudomonas
may be fulminant and even fatal, requiring extensive surgical procedures for control.
...
PMID:Sinusitis in immunodeficient and immunosuppressed patients. 388 Aug 49
In vitro experiment with phagocytic and bactericidal activity of human neutrophils, SM-4300 augmented opsonic activity against
Pseudomonas
aeruginosa. After a single dose of 200 mg/kg body weight SM-4300 to a child with common variable
immunodeficiency
(CVI), serum IgG concentration/time curve was similar to that after PEG-Ig administration. In combination therapies with SM-4300 and antibiotics in 8 children with bacterial infections, beneficial efficacy of SM-4300 was observed. There was no adverse reaction in 16 times injections to 9 children with bacterial infections and 5 times to a child with CVI.
...
PMID:[Clinical studies of SM-4300 in children]. 393 27
The AIDS syndrome includes cases of biopsy-proven Kaposi's sarcoma in persons under 60 years of age, or biopsy- or culture-proven Pneumocystis carinii pneumonia, or either of the life-threatening opportunistic infections in young previously healthy persons with no underlying cause of
immunodeficiency
(Center for Disease Control criteria). Here we described the first case of AIDS with early Kaposi's sarcoma-like lesions in homosexual male drug addict and have compared the clinical and laboratory findings with those of another homosexual male having recrudescent melioidosis due to
Pseudomonas
pseudomallei.
...
PMID:A case comparison of acquired immune deficiency syndrome (AIDS) in homosexual males with spindle-endothelial cell abnormalities and with recrudescent melioidosis. 407 77
Bacteremia in patients with cystic fibrosis (CF) has not been previously reported, a fact probably attributable to activated systemic immunity in the presence of chronic bronchopulmonary infection. We have observed two CF patients under a year of age with documented bacteremia, and a teen-aged patient with autopsy evidence of premortem bacteremia. Organisms were Staphylococcus aureus, Serratia marcescens, and
Pseudomonas
aeruginosa, having presumably spread from the lower respiratory tract in both patients. None of the patients had historical or laboratory evidence of
immunodeficiency
. The true incidence of bacteremia in CF patients is unknown, and the circumstances under which it occurs have not yet been defined.
...
PMID:Bacteremia in patients with cystic fibrosis. 700 Apr 10
The U.S. Centers for Disease Control and Prevention (CDC) recommends that only heat sterilization be used for all reusable devices entering the oral cavity. However, chemical disinfection is still employed for reprocessing dental devices in many areas of the world. In an analysis of a Florida dental practice responsible for nosocomial human
immunodeficiency
virus (HIV) transmissions, the possible role of contaminated devices was deemed unlikely in part because they were subjected to high-level disinfection with 2% glutaraldehyde. Disease transmissions have, however, been documented for endoscopes used in diagnostic and surgical procedures even after this treatment. In some dental devices, lubricants mix with potentially infectious patient materials, and organic debris has been observed in endoscopes after cleaning. We have investigated whether lubricants can render high-level chemical disinfection procedures ineffective and have addressed the role that some common devices may play in disease transmission. We report here that HIV in whole-blood samples and
Pseudomonas
aeruginosa in blood and plasma survived high-level disinfection when entrapped in lubricants used in dental handpieces and endoscopes. We also found that lubricated dental devices used to clean and polish teeth (prophylaxis angles) have the potential to transfer sufficient amounts of blood to infect human lymphocyte cultures with HIV. These results emphasize the need to subject reusable dental devices to a heat-sterilization protocol that penetrates the lubricant.
...
PMID:Resistance of microorganisms to disinfection in dental and medical devices. 748 88
A big problem of nosocomial infections is some refractory infections, so that present important nosocomial infections are deep infections by MRSA and weakly virulent gram-negative bacilli such as
Pseudomonas
aeruginosa, which are not susceptible to many antimicrobial agents. It is also noteworthy that MRSA can infect to both immunonormal and immunocompromised patients, although clinical signs of that infection are much more severe in the latters. On the other hand, weakly virulent bacilli can infect to only immunocompromised patients. Immunocompromised states are divided into two categories, namely general and local deficiencies. The mechanism of general
immunodeficiency
is mainly depend upon leukopenia or diminishment of phagocytic activity of them, and that of local
immunodeficiency
is bases on formation of biofilms which protect bacteria from phagocytosis and killing effect of antimicrobial agents. In this paper, it is emphasized that both countermeasure for nosocomial infections and adequate use of antimicrobial agents or immunomodulators are necessary to decrease number of patients with hospital infections.
...
PMID:[Nosocomial infections]. 768 66
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>